CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 36 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-28 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale 10b5-1 | −6,368 | $60.17 | $383K | 702 |
| 2026-08-28 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale 10b5-1 | −700 | $60.98 | $43K | 2 |
| 2026-03-13 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale 10b5-1 | −1,410 | $55.23 | $78K | 7,069 |
| 2026-03-12 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Exercise or conversion 10b5-1 | +3,750 | 8,479 | ||
| 2026-03-12 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Exercise or conversion · Restricted Share Units 10b5-1 | −3,750 | 11,250 | ||
| 2026-03-10 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale 10b5-1 | −2,771 | $60.11 | $167K | 4,729 |
| 2026-03-09 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Exercise or conversion 10b5-1 | +7,500 | 7,500 | ||
| 2026-03-09 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Performance Share Units 10b5-1 | +7,500 | 7,500 | ||
| 2026-03-09 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Exercise or conversion · Performance Share Units 10b5-1 | −7,500 | 0 | ||
| 2026-01-09 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +100,000 | 100,000 | ||
| 2026-01-09 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Restricted Share Units | +20,000 | 20,000 | ||
| 2025-03-12 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +80,000 | 80,000 | ||
| 2025-03-12 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Restricted Share Units | +15,000 | 15,000 | ||
| 2024-03-11 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2023-03-24 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Sale | −700 | $35.01 | $25K | 0 |
| 2023-03-10 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +120,000 | 120,000 | ||
| 2022-03-10 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-01-21 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Purchase | +700 | $28.81 | $20K | 700 |
| 2021-08-23 | KENNEY CHRISTOPHER JOHN Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 |
Page 1 of 1 · 19 trades